Inventor
DAI GUANGXIU
CN14 patents
⚠️ This page may combine multiple inventors who share the name “DAI GUANGXIU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HUTCHISON MEDIPHARMA LTD
12 patentsUS11478474B2Oct 25, 2022
2-(3′-(hydroxymethyl)-1-methyl-5-((5-(2-methyl-4-(oxetan-3-yl)piperazin-1-yl)pyridin-2-yl)amino)-6-oxo-1,6-dihydro-[3,4′-bipyridin]-2′-yl)-7,7-dimethyl-7,8-dihydro-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1(6H)-one as a BTK inhibitor
HUTCHISON MEDIPHARMA LTD2 citations72
US10512645B2Dec 24, 2019
Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor
HUTCHISON MEDIPHARMA LTD2 citations72
US9956218B2May 1, 2018
Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor
HUTCHISON MEDIPHARMA LTD2 citations72
US10208066B2Feb 19, 2019
Imidazopyridazine compounds and their use
HUTCHISON MEDIPHARMA LTD4 citations68
US12234211B2Feb 25, 2025
Cycloolefin substituted heteroaromatic compounds and their use
HUTCHISON MEDIPHARMA LTD0 citations62
US12173008B2Dec 24, 2024
Substituted piperazines as BTK inhibitors
HUTCHISON MEDIPHARMA LTD0 citations62
US12070457B2Aug 27, 2024
Substituted pyridines, pyridazines, pyrimidines, and 1,2,3-triazines as bruton's tyrosine kinase inhibitors
HUTCHISON MEDIPHARMA LTD0 citations62
US11896592B2Feb 13, 2024
Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor
HUTCHISON MEDIPHARMA LTD0 citations62
US11655254B2May 23, 2023
Substituted piperazines as BTK inhibitors
HUTCHISON MEDIPHARMA LTD0 citations62
US11414390B2Aug 16, 2022
Cycloolefin substituted heteroaromatic compounds and their use
HUTCHISON MEDIPHARMA LTD0 citations62
US10946014B2Mar 16, 2021
Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor
HUTCHISON MEDIPHARMA LTD0 citations62
US10611777B2Apr 7, 2020
Imidazopyridazine compounds and their use
HUTCHISON MEDIPHARMA LTD0 citations51